EHC (STOCKS)
Encompass Health Corporation Common Stock
$123.550000
-1.280000 (-1.03%)
Prev close: $124.830000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Mark J. Tarr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,520.44M
- Employees
- 29,198
- P/E (TTM)
- 20.33
- P/B (TTM)
- 4.75
- Dividend Yield
- 60.88%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.55 | $1.49 | +0.0556 | +3.72% |
|
Mar 2026 (Q1)
|
$1.60 | $1.51 | +0.0881 | +5.83% |
|
Dec 2025 (Q4)
|
$1.46 | $1.31 | +0.1488 | +11.35% |
|
Sep 2025 (Q3)
|
$1.23 | $1.21 | +0.0234 | +1.94% |
Financial Statements
| Revenues | $6.21B |
| Benefits Costs and Expenses | $5.18B |
| Costs And Expenses | $5.09B |
| Operating Expenses | $5.09B |
| Operating Income/Loss | $1.12B |
| Income/Loss Before Equity Method Investments | $1.03B |
| Income/Loss From Continuing Operations After Tax | $817.60M |
| Income/Loss From Continuing Operations Before Tax | $1.03B |
| Income/Loss From Discontinued Operations Net Of Tax | $15.70M |
| Income/Loss From Equity Method Investments | $2.50M |
| Income Tax Expense/Benefit | $210.30M |
| Income Tax Expense/Benefit, Deferred | $22.40M |
| Net Income/Loss | $833.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $212.30M |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | $201.50M |
| Net Income/Loss Attributable To Parent | $621.00M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $10.80M |
| Net Income/Loss Available To Common Stockholders, Basic | $619.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.60M |
| Preferred Stock Dividends And Other Adjustments | $1.60M |
| Basic Earnings Per Share | $6.22 |
| Diluted Earnings Per Share | $6.14 |
| Basic Average Shares | 298,500,000 |
| Diluted Average Shares | 302,800,000 |
| Assets | $7.46B |
| Current Assets | $1.04B |
| Accounts Receivable | $687.30M |
| Other Current Assets | $353.70M |
| Noncurrent Assets | $6.42B |
| Intangible Assets | $306.80M |
| Other Non-current Assets | $6.11B |
| Liabilities | $4.00B |
| Current Liabilities | $873.40M |
| Accounts Payable | $221.60M |
| Other Current Liabilities | $651.80M |
| Noncurrent Liabilities | $3.12B |
| Redeemable Noncontrolling Interest | $57.90M |
| Equity | $3.40B |
| Equity Attributable To Noncontrolling Interest | $805.50M |
| Equity Attributable To Parent | $2.60B |
| Temporary Equity | $57.90M |
| Liabilities And Equity | $7.46B |
| Net Cash Flow From Operating Activities | $1.23B |
| Net Cash Flow From Operating Activities, Continuing | $1.21B |
| Net Cash Flow From Operating Activities, Discontinued | $20.80M |
| Net Cash Flow From Investing Activities | -$826.40M |
| Net Cash Flow From Investing Activities, Continuing | -$826.40M |
| Net Cash Flow From Financing Activities | -$390.00M |
| Net Cash Flow From Financing Activities, Continuing | -$390.00M |
| Net Cash Flow | $16.90M |
| Net Cash Flow, Continuing | -$3.90M |
| Net Cash Flow, Discontinued | $20.80M |
| Comprehensive Income/Loss | $832.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $212.30M |
| Comprehensive Income/Loss Attributable To Parent | $620.30M |
| Other Comprehensive Income/Loss | -$700.00K |